Log In
Print
BCIQ
Print
Print this Print this
 

Exparel (formerly DepoBupivacaine)

  Manage Alerts
Collapse Summary General Information
Company Pacira Pharmaceuticals Inc.
DescriptionBupivacaine liposome extended-release injectable suspension using DepoFoam drug delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsManage postsurgical pain following total knee arthroplasty; Nerve block; Treat non-surgical pain; Treat postoperative pain; Treat postoperative pain following thoracotomy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$43.5M

$1.0M

$42.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today